XOMA
Emeryville · Founded 1981
About XOMA
XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation today. Building on a pioneering proprietary pipeline, a world-class antibody discovery and development platform, plus multiple revenue streams, XOMA is creating innovative human antibody therapeutics with the potential to transform medicine and reshape people's lives.
Company Facts
- Founded: 1981
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $420.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:XOMA
- Website: xoma.com
- Phone: +1-510-204-7200
Industries & Categories
Biotechnology, Developer Platform, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/xoma-44241 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.